Researchers investigated cellular effects of pan-Janus Kinase inhibitor tofacitinib and the corticosteroid budesonide on uninflamed and TNF + Poly(I:C) stimulated human colon organoids from healthy donors and inflammatory bowel disease-patients.
[Scientific Reports]